IP Library › Granted Patent US 8,071,641
Granted Patent B2
US 8,071,641 · App. 10/589,623 · Granted Dec 6, 2011

Treating or preventing diabetes with cannabidiol

Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem; Hadsit Hadasit Medical Research Services and Development Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,071,641
App. No.
10/589,623
Granted
Dec 6, 2011
Kind
B2
Abstract

Use of a cannabidiol for the manufacture of a medicament identified for the treatment or prevention of diabetes and/or insulitis.

Claims (5)

1. A method of treating Type II diabetes in a subject, the method comprising administering to the subject a therapeutically effective amount of cannabidiol (CBD), wherein said cannabidiol is comprised in a composition having no psychotropic activity, thereby treating type II diabetes in the subject.

2. The method of claim 1 , wherein said administering is via parenteral administration.

3. The method of claim 1 , wherein said administering is via oral administration.

4. The method of claim 1 , wherein said administering is via transdermal administration.

5. The method of claim 1 , wherein said subject has transplanted pancreatic cells.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2008
From: GALLILY, RUTH; MECHOULAM, RAPHAEL
To: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM
Reel/Frame 020847/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2008
From: SLAVIN, SHIMON; WEISS, LOLA; ZEIRA, MICHAEL
To: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
Reel/Frame 020463/0831 →
Priority Claims (1)
IL 160420 · Feb 16, 2004 · national
Continuity (1)
Related Publication 20070099987A1 · May 3, 2007